Endosomal/lysosomal retention and degradation of major histocompatibility complex class I molecules is induced by Myxoma virus

Martha C. Zúñiga, Hong Wang, Michele Barry, Douglas McFadden

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The highly immunosuppressive leporipoxvirus myxoma, previously was shown to promote the loss of cell surface class I major histocompatibility complex (MHC l) molecules. Here, we show that myxoma virus induces the loss of both cell surface and intracellular post-Golgi, β2-microglobulin-associated MHC I. Myxoma-induced loss of these MHC I molecules is abrogated by vacuolar ATPase inhibitors, NH4Cl, and leupeptin. Furthermore, immunofluorescence microscopic studies reveal that in myxoma-infected cells, β2-microglobulin- associated MHC l accumulates in Lamp-1+ vesicular structures, suggesting that myxoma virus targets MHC I for degradation in late endosomes and/or lysosomes. These events are regulated by early gene product or products because they occur unabated in cells infected with myxoma virus in the presence of cytosine arabinoside, an inhibitor of DNA synthesis. Studies with baby green monkey kidney cells transfected with wild-type and tail-less forms of a mouse MHC I molecule, H-2L(d), indicate that the MHC I cytoplasmic tail is required for myxoma-induced localization in Lamp-1+ organelles. Myxoma- induced endocytosis and degradation of MHC I may provide the virus with a means of dispensing with cell surface MHC I molecules that were loaded with peptides derived from viral proteins synthesized early in infection.

Original languageEnglish (US)
Pages (from-to)180-192
Number of pages13
JournalVirology
Volume261
Issue number2
DOIs
StatePublished - Sep 1 1999
Externally publishedYes

Fingerprint

Myxoma virus
Myxoma
Major Histocompatibility Complex
Leporipoxvirus
Tail
Vacuolar Proton-Translocating ATPases
Nucleic Acid Synthesis Inhibitors
Cercopithecus aethiops
Endosomes
Cytarabine
Viral Proteins
Immunosuppressive Agents
Endocytosis
Lysosomes
Organelles
Fluorescent Antibody Technique
Viruses
Kidney
Peptides
Infection

ASJC Scopus subject areas

  • Virology

Cite this

Endosomal/lysosomal retention and degradation of major histocompatibility complex class I molecules is induced by Myxoma virus. / Zúñiga, Martha C.; Wang, Hong; Barry, Michele; McFadden, Douglas.

In: Virology, Vol. 261, No. 2, 01.09.1999, p. 180-192.

Research output: Contribution to journalArticle

@article{9836c6be3a494b5dac0f6ce753f107eb,
title = "Endosomal/lysosomal retention and degradation of major histocompatibility complex class I molecules is induced by Myxoma virus",
abstract = "The highly immunosuppressive leporipoxvirus myxoma, previously was shown to promote the loss of cell surface class I major histocompatibility complex (MHC l) molecules. Here, we show that myxoma virus induces the loss of both cell surface and intracellular post-Golgi, β2-microglobulin-associated MHC I. Myxoma-induced loss of these MHC I molecules is abrogated by vacuolar ATPase inhibitors, NH4Cl, and leupeptin. Furthermore, immunofluorescence microscopic studies reveal that in myxoma-infected cells, β2-microglobulin- associated MHC l accumulates in Lamp-1+ vesicular structures, suggesting that myxoma virus targets MHC I for degradation in late endosomes and/or lysosomes. These events are regulated by early gene product or products because they occur unabated in cells infected with myxoma virus in the presence of cytosine arabinoside, an inhibitor of DNA synthesis. Studies with baby green monkey kidney cells transfected with wild-type and tail-less forms of a mouse MHC I molecule, H-2L(d), indicate that the MHC I cytoplasmic tail is required for myxoma-induced localization in Lamp-1+ organelles. Myxoma- induced endocytosis and degradation of MHC I may provide the virus with a means of dispensing with cell surface MHC I molecules that were loaded with peptides derived from viral proteins synthesized early in infection.",
author = "Z{\'u}{\~n}iga, {Martha C.} and Hong Wang and Michele Barry and Douglas McFadden",
year = "1999",
month = "9",
day = "1",
doi = "10.1006/viro.1999.9840",
language = "English (US)",
volume = "261",
pages = "180--192",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Endosomal/lysosomal retention and degradation of major histocompatibility complex class I molecules is induced by Myxoma virus

AU - Zúñiga, Martha C.

AU - Wang, Hong

AU - Barry, Michele

AU - McFadden, Douglas

PY - 1999/9/1

Y1 - 1999/9/1

N2 - The highly immunosuppressive leporipoxvirus myxoma, previously was shown to promote the loss of cell surface class I major histocompatibility complex (MHC l) molecules. Here, we show that myxoma virus induces the loss of both cell surface and intracellular post-Golgi, β2-microglobulin-associated MHC I. Myxoma-induced loss of these MHC I molecules is abrogated by vacuolar ATPase inhibitors, NH4Cl, and leupeptin. Furthermore, immunofluorescence microscopic studies reveal that in myxoma-infected cells, β2-microglobulin- associated MHC l accumulates in Lamp-1+ vesicular structures, suggesting that myxoma virus targets MHC I for degradation in late endosomes and/or lysosomes. These events are regulated by early gene product or products because they occur unabated in cells infected with myxoma virus in the presence of cytosine arabinoside, an inhibitor of DNA synthesis. Studies with baby green monkey kidney cells transfected with wild-type and tail-less forms of a mouse MHC I molecule, H-2L(d), indicate that the MHC I cytoplasmic tail is required for myxoma-induced localization in Lamp-1+ organelles. Myxoma- induced endocytosis and degradation of MHC I may provide the virus with a means of dispensing with cell surface MHC I molecules that were loaded with peptides derived from viral proteins synthesized early in infection.

AB - The highly immunosuppressive leporipoxvirus myxoma, previously was shown to promote the loss of cell surface class I major histocompatibility complex (MHC l) molecules. Here, we show that myxoma virus induces the loss of both cell surface and intracellular post-Golgi, β2-microglobulin-associated MHC I. Myxoma-induced loss of these MHC I molecules is abrogated by vacuolar ATPase inhibitors, NH4Cl, and leupeptin. Furthermore, immunofluorescence microscopic studies reveal that in myxoma-infected cells, β2-microglobulin- associated MHC l accumulates in Lamp-1+ vesicular structures, suggesting that myxoma virus targets MHC I for degradation in late endosomes and/or lysosomes. These events are regulated by early gene product or products because they occur unabated in cells infected with myxoma virus in the presence of cytosine arabinoside, an inhibitor of DNA synthesis. Studies with baby green monkey kidney cells transfected with wild-type and tail-less forms of a mouse MHC I molecule, H-2L(d), indicate that the MHC I cytoplasmic tail is required for myxoma-induced localization in Lamp-1+ organelles. Myxoma- induced endocytosis and degradation of MHC I may provide the virus with a means of dispensing with cell surface MHC I molecules that were loaded with peptides derived from viral proteins synthesized early in infection.

UR - http://www.scopus.com/inward/record.url?scp=19244367349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19244367349&partnerID=8YFLogxK

U2 - 10.1006/viro.1999.9840

DO - 10.1006/viro.1999.9840

M3 - Article

C2 - 10497104

AN - SCOPUS:19244367349

VL - 261

SP - 180

EP - 192

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -